Inclusion Criteria:  Healthy male or non pregnant female aged ≥ 18 years Subjects must have provided IRB approved written informed consent Subjects must have clinical diagnosis of interdigital tinea pedis with lesions localized to the interdigital spaces or predominantly interdigital, but may extend to other areas of the foot (the non-interdigital lesions should not be hyperkeratotic, i.e., characteristic of tinea pedis moccasin).  Exclusion Criteria:  Female Subjects who are pregnant, nursing or planning to become pregnant during study participation. Subjects with a history of hypersensitivity or allergy to any of the study medication ingredients and its excipients. Confluent, diffuse moccasin-type tinea pedis of the entire plantar surface.